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GSA and The Politics of Creative 
Engagement: “for the common good”
As the Glasgow School of Art prepares to celebrate its 175th 
anniversary, in 2020, we can reflect upon the relationship the 
Institution has had with the city of Glasgow, Scotland and 
the UK, our European neighbours and an increasingly inter-
connected global audience for the work produced by students 
and faculty. Founded in 1845 as a Government School of 
Design and building upon our origins in the Foulis Academy 
and the Scottish Enlightenment, GSA has pioneered 
advances in the creative disciplines and contributions to 
aesthetic exploration. With the recent addition of both the 
School of Simulation & Visualisation and The Innovation 
School to the historic Schools of Fine Art, Architecture, and 
Design, this proud tradition continues. 
The expansion of the intellectual and aesthetic repertoire 
facilitated by new academic Schools and the emergence of 
novel disciplines ensures the translation of proud tradition 
into contemporary relevance. GSA continues to honour 
its past as it engages with the present and imagines our 
future(s), and it does so in the spirit of “the common good,” 
of greatest benefit for all, students, teachers and citizens. 
This is the ethos that underpins the Precision Medicine project 
described in these pages, a collaboration between Product 
Design bachelor students at the GSA’s Innovation School and 
the scientists and clinicians of the University of Glasgow’s 
Institute of Cancer Sciences, born of the synthesis of creative 
exploration and scientific expertise.
The Glasgow School of Art’s pursuit of creative 
engagement with others, with the users and stakeholders 
of the design process, our fellow citizens, our academic 
colleagues at the University of Glasgow and their world class 
expertise, lies at the core of this project. It is the combination 
of cutting edge science with the intellectual exploration 
of designers that gives birth to the innovative products, 
services, interactions and experiences detailed here. This 
publication seeks to capture the possibilities of tomorrow 
and offer them up for scrutiny, today. In this sense 
creative engagement is an invitation to all, to enter a debate 
regarding our shared future, an opportunity for designers 
and innovators to make available to citizens the chance to 
say how we might wish to live, and to care for others. This 
is the tradition, of innovation open to all, that the Glasgow 
School of Art embodies and seeks to share.
Dr Gordon Hush
Head of The Innovation School



























Precision medicine is currently leading a healthcare 
revolution that places citizens at the centre of a discussion 
about their own care and wellbeing. This pioneering 
Future Experiences project by the Innovation School’s 
graduating BDes students examines how cancer care, in 
particular, can be tailored to meet the specific needs of 
individual patients. It explores the evolving landscape of 
cancer treatment and proposes alternative futures that are 
innovative, credible, practical and provocative.
The students were asked to develop visions of a future 
world in which advances in information technologies, 
artificial intelligence and genetic profiling have ushered in 
a new era of personalised health. Their projects explore the 
potential implications of precision medicine on stakeholders 
ranging from patients and their families, to policy makers, 
medical professionals and pharmaceutical firms. Key areas 
of focus include the shifting relationship between patients 
and healthcare providers, the pros and cons of increased 
access to our genomic information, and how personal health 
data should be safely stored and shared.
A collaboration with the University of Glasgow’s 
Institute of Cancer Sciences provided direct access to 
patients and experts embedded in the current world of 
precision medicine and cancer care. The students employed 
a variety of techniques and methodologies in order to 
gather information and develop solutions to real-world 
issues that arose from their research. The diverse range of 
products, services and experiences they proposed highlights 
unforeseen opportunities to revolutionise the future of 


















About The Innovation School
Precision Medicine: 
a personalised approach to healthcare
The Innovation School at The Glasgow School of Art is 
a leading centre for design teaching that focuses on the 
key issues impacting contemporary society. Rather than 
concentrating on the more conventional interpretation 
of design in an industrial context, students learn how to 
generate innovative solutions that foreground the user 
experience. This post-disciplinary approach to Product 
Design encourages students to consider the needs of the 
end user and other stakeholders when developing proposals 
for building a better world.
Through collaborations, such as this one with the 
University of Glasgow, our students apply their creative 
skills and knowledge to real-world scenarios. By adopting a 
participatory approach that involves various stakeholders 
throughout the process, they are able to devise human-
centred solutions that could play a genuinely positive and 
disruptive role in the future of our rapidly evolving society.
This Future Experiences project focuses on the emerging 
field of precision medicine and examines its potential to 
revolutionise how certain diseases are diagnosed and 
treated. Precision medicine aims to match treatments to 
individual patients by taking into account their genetic 
make up, medical history, test results and other distinctive 
biological and biographical characteristics. This tailored 
approach to healthcare puts the patient at the centre 
of a discussion about their own care and wellbeing. 
Technological advances are enabling data including genetic 
information to form the basis for personalised treatments 
or lifestyle choices that could profoundly affect the future 
relationship between the public and healthcare providers.
Advances in genomic medicine are having a particularly 
significant impact on contemporary medical practice, as 
faster and more affordable genetic sequencing technologies 
facilitate more widespread use of genomic information in 
the realm of clinical care. The Human Genome project, 
which began in 1990 and succeeded in mapping the entire 
sequence of human DNA, has far-reaching implications 
for a future in which genetic information is used to treat 
patients in a very specific manner, or to preempt certain 
conditions and encourage a more preventative approach 
to treatment. In this context, the traditional relationship 
between doctor and patient is being transformed, with 
patients assuming far greater control and commercial 
enterprises offering gene-profiling services that could 
support self-diagnosis, and even treatment.
Other technological advances are also affecting the way 
we approach healthcare, with online services, digital health 
trackers, apps and wearables allowing users to generate 
data about their personal health. This data holds great 
value for companies developing new drugs, as well as for 
clinicians performing trials or looking for ways to tackle 
diseases such as cancer. 
Against this backdrop of unprecedented scientific and 
technological progress, the Innovation School’s students 
focused on the human issues arising from the evolution 
of precision medicine. They examined the various 
stakeholders involved and the ways in which emerging 
technologies will affect patients, healthcare providers, 
researchers, policy makers and commercial organisations. 
The era of personalised medicine will require collaboration 
between all of these stakeholders, and the Future 
Experiences project provides a range of visionary concepts 
for uniting people in the pursuit of a common goal.
Why Precision Medicine?
The aim of the Future Experiences project is to confront 
students with a live subject that tests their ability to 
examine and respond to important contemporary issues. 
It provides an opportunity for them to demonstrate how 
advanced research and design methodologies can be used to 
develop a vision for an enhanced future world.
Precision medicine is evolving at a staggering speed, 
and has the potential to radically alter how healthcare 
is provided in the coming years. In his 2015 State of the 
Union address, President Barack Obama launched the 
Precision Medicine Initiative, claiming that the ability to 
match a cancer cure to a patient’s genetic code could soon 
become as standard as performing a blood transfusion 























definition of precision medicine that outlined its potential to 
deliver “the right treatments, at the right time, every time 
to the right person”. Obama’s speech helped to put precision 
medicine in the public spotlight, and it continues to make the 
news as businesses, scientists and healthcare providers seek to 
exploit its enormous potential. 
The implications of adopting a more personal approach to 
healthcare are profound and varied. The students were asked 
to respond to the theme of “Personalised Health in a Consumer 
Age” and to imagine how the cancer landscape will look ten 
years from now. The numerous technical, ethical and social 
considerations arising from this issue formed an appropriate 
foundation for a future-focused design project that examines 
the needs and aspirations of specific groups of users or 
stakeholders. The brief provided opportunities for the students 
to conduct detailed desk and field research, which informed the 
development of socially driven experiences that are enabled or 
afforded by precision medicine.
The Innovation School regularly works with the NHS and 
other organisations on health-based projects, so the students 
are part of a hub for research and innovation relating to 



















The main goal of this academic project was to encourage design 
students to engage with an important topic confronting society, 
and present proposals for a highly resolved design experience. 
The students were afforded an opportunity to demonstrate the 
skills, methods and approaches used to engage with, design for 
and envision the future in relation to the theme of Personalised 
Heath. This experience mirrors the sorts of analytical and 
strategic skills valued by the design industry and organisations 
involved with setting the future agenda for areas such as policy 
making, finance and healthcare. They were assessed based on 
their group research and individual outcomes, with the grades 
contributing to their final degree mark.
Alongside its primary academic scope, the Future 
Experiences project exemplifies the Innovation School’s 
commitment to partnering with businesses and institutions 
on projects that have significant mutual benefits. This project 
involved working closely with scientists, clinicians, patients 
and academic professionals from the University of Glasgow, 
staff at Queen Elizabeth Hospital’s Clinical Innovation Zone, 
and staff from Beatson West of Scotland Cancer Centre, as well 
as patient representatives and external design experts to ensure 
all stakeholder needs were explored. This collaboration enables 
our project partners to gain a new perspective on their own 
practice and an appreciation for the way design can be used to 
help identify new ideas and alternative ways of working. The 
project culminated in a final presentation that was attended 
by members of the public, as well as the media and peers of our 
various project partners. Insights generated during the process 
and the final outcomes were also compiled by the University of 
Glasgow as a dataset that can be accessed using the following 
Digital Object Identifier (DOI): 10.5525/gla.researchdata.843
precision medicine, with the University of Glasgow pioneering 
a multidisciplinary approach that promotes collaboration 
between academia, industry and the NHS. Through our 
partnership with the university, the students benefited from 
input from researchers, academics and industry professionals at 
the front line of precision medicine. The access to experts and 
physical sites where work on precision medicine is taking place 
provided exceptional opportunities for a speculative project 













































—Design academic and lecturer 
    in the Innovation School
Kirsty teaches across the Product Design undergraduate 
programme at the Innovation School and is responsible for 
the coordination of the final year curriculum for both the 
BDes and MEDes pathways. As lead tutor on the Future 
Experiences project, she was responsible for setting the 











We try to identify a future context 
that is linked to a significant 
technological or scientific 
advancement. Challenging the students to explore a topic that’s future 
focused and emerging in society gives them a chance to add something 
to their portfolio that is really contemporary or ahead of industry.
Health is becoming a huge area 
for design and we have a lot of 
graduates working within that field. 
Having an undergraduate project 
examine that area complements the research being conducted elsewhere in 
the Innovation School and helps to form a cluster of knowledge. 
From a methodology point 
of view I’m very interested in 
future-focused design practice, 
and this project utilises a lot of 
the methods and approaches we 
teach across the undergraduate 
programme. Consolidating these ideas as a project framework that 
introduces a coherent future-focused design process allows the students 
to apply these methods along with their own skills and experience. 
The translation and interpretation 
of the research into a physical 
materialisation of a future world 
was really exciting. It asks them 
to communicate and describe 
their findings using semantics 
and making. It’s about making 
the research and knowledge tangible by creating something that can be 
experienced and understood by other people. It uses the power of making 
in a slightly different way than in traditional product design.
The students have demonstrated 
the skills, methods and approaches 
used to engage with, design for 
and envision the future in relation 
to a thematic future context. As an exploration of health, medicine and 
What is the main aim of the Future 
Experiences project?
Why did you choose personalised 
health as the area of focus for this 
project?
How did the brief you devised 
provide a framework for the 
students to demonstrate different 
human-centred design methods 
and techniques?
You commissioned design 
professionals to run workshops 
that focused on methods for 
effectively communicating 
research. Why did you feel this was 
important for the project?
What skills and expertise have the 
students been able to showcase 
throughout this project? 
design, the project required the students to embrace a level of intellectual and 
creative mobility and flexibility of approach. Through this they gained real 
experience of the professional practice involved in inter-disciplinary design, 
and developed the awareness and ability to learn and work collaboratively 
across teams, disciplines and platforms – a mindset and approach that is of 
great value within the design industry and contemporary design practice.
As the creator of the project and 
the academic lead, one of the most 
rewarding aspects is seeing how 
the students bring the project to 
life. They exceeded my expectations 
in this respect. They embraced 
the challenge of understanding an emerging scientific area, interrogated 
the complex context of cancer care and treatment, gave it meaning and 
definition, and delivered provocative design responses. The outcomes are 
impressive in terms of their creative extrapolation of the research – a diverse 
range of credible and challenging design propositions that range from future 
systems, to services and connected products.
What are your thoughts on the 
proposals and how they respond 
to the real-world implications of 





































DESK AND FIELD 
RESEARCH
At the Innovation School, our students conduct 
meaningful, targeted desk research in order 
to gain a thorough understanding of the topic 
they are addressing. In the case of this Future 
Experiences project, the first phase of the research 
was conducted in groups over an intensive three-
week period. The aim of this process was to gather 
information and generate a detailed overview 
of how the evolution of precision medicine is 
affecting current practices within cancer care. 
The groups then presented their research in the 
form of a Future Vision that placed their findings 
in a speculative real-life context.
The research process was structured around 
the STEEEPLE cards methodology developed 
by lead tutor Kirsty Ross and previous student 
cohorts, which allowed the cohort to examine 
a wide range of factors that are relevant to the 
field of precision medicine. Each of the eight 
groups was given a specific area of focus and 
tasked with gathering information in a way that 
could be easily communicated to their peers. By 
researching the social, technological, economic, 
ethical, educational, political, legal and ecological 
implications of precision medicine, the groups 
were able to collaboratively compile insight and 
uncover areas of opportunity that helped to 
guide the design phase. The STEEEPLE cards 
provided a way to capture, analyse and activate 
the desk research. Each student was tasked with 
generating approximately ten cards, which were 
then clustered into different arrangements to help 



















As part of this initial research phase, some of 
the students also undertook field research to 
gather more in-depth insight into specific factors 
relevant to their group’s theme. Students from 
the economic group attended a meeting of the 
In-House Trials Advisory Board (IHTAB) at the 
Beatson West of Scotland Cancer Centre, which 
makes decisions about clinical trial resource. 
Other students visited the Pathology Department 
at the Queen Elizabeth University Hospital to 
witness how pathology specimens are run. This 
field research enabled the students to observe 
and analyse key relationships and interactions 
between different stakeholders. They were able 
to question the various experts they met with 
STEEEPLE cards are a very interesting method for 
capturing research. Giving eight groups a single 
dimension to focus on worked as a way to distinguish 
each group and bring their research together for 
collective review. The cards are a prompt to facilitate 
discussion between the groups, as well as enabling 
them to distill their research, commit to it and make 
decisions about what it means. It’s an effective way to 
create collective knowledge for the whole cohort.
Kirsty Ross
Some provocations arising from the desk research
 — How does the accurate information 
precision medicine provides alter patients’ 
perceptions of their treatment options? 
 — In ten years’ time, will people make key 
lifestyle/relationship decisions based on 
genomic information? 
 — Under what circumstances might 
corporations be given access to an 
individual’s health data, and how should 
they be allowed to use it? 
 — Might removing the stigma associated with 
cancer lead to changes in attitudes and 
behaviours?
 — What role will artificial intelligence play 
in the future of diagnosis and prescribing 
treatments?
 — If precision medicine is prohibitively 
expensive, how should this be balanced 
against more accessible care for the 
majority?
to deepen their understanding of real-world 
scenarios and gained a personal perspective that 
informed their future proposals.
Throughout this research phase, several areas 
of overlap between the different STEEEPLE 
topics were identified. These helped to generate 
key themes that formed the basis for further 
exploration and more targeted conversations 
with stakeholders. The research also prompted 
the students to identify a range of important, 
human-centred provocations based on the 
hopes, fears and opportunities outlined by the 
different collaborators. Several of these issues 
were addressed directly by students in the design 
phase, providing a launchpad for examining the 
potential consequences of any interventions on 
various stakeholders. These sorts of provocations 
exemplify the ability of the Innovation School’s 
students to translate research into areas of 



























































Student work: Collating and 
visualising complexity



































As part of their research into the real-life 
implications of precision medicine, the cohort 
visited The University of Glasgow’s Clinical 
Innovation Zone (CIZ) at the new Queen Elizabeth 
Hospital campus. The building accommodates 
high-specification units intended to promote 
innovation and provide access to world-leading 
clinical academics, research facilities and industry 
partners all on one site. As a home to companies 
specialising in precision medicine, imaging and 
diagnostics, the Clinical Innovation Zone is one 
of the best places in the world to learn about the 
people pioneering future applications in this 
emerging field.
The CIZ champions a ‘Triple Helix’ partnership 
with industry and the NHS to accelerate the 
implementation of precision medicine – an 
innovative approach bringing benefits to patients, 
savings to the NHS and creating an exemplar 
life-sciences cluster to drive economic growth 
in Glasgow. The visiting students learned about 
co-located partners, ranging from start-ups 
and spinouts to major corporate partners, and 
actively engaged with the development process for 
diagnostics and the roles that industry, academia 
and NHS play.
During the visit to the Collaboration Zone 
within the university’s Imaging Centre of 
Excellence (ICE), the students were met by experts 
based at the facility, who explained their roles 
and showed them around the building. Jonathan 
Scott, ICE and Strategic Projects Manager, and 
Dr Ruth McLaughlin from the Glasgow Molecular 
Pathology Node of The University of Glasgow 
































The group also met with Harper VanSteenhouse, 
the General Director of personalised diagnostics 
company BioClavis Ltd, who relocated from the 
USA to Glasgow to benefit from the opportunities 
provided by being part of the community at the 
Clinical Innovation Zone.
advantages of being based at a major centre 
for multidisciplinary research, innovation and 
commercialisation in precision medicine. 
The students were interested in the role that 
innovation and the CIZ are playing in a much wider 
innovation-led investment strategy planned across 
the city of Glasgow, which will further drive economic 
and physical regeneration and bring an increased 
connectivity, physically embodied in a new bridge 
spanning the River Clyde.
Jonathan Scott, ICE and Strategic Projects Manager
From our visit to the Clinical Innovation Zone I 
observed the importance of access to key hubs of 
activities involved within research topics. I was able 
to form relationships that saw me invited back to the 
hub to re-engage with artefacts and assumptions that 
helped to validate and challenge my project direction. 
Alex Lister, graduating student
This field research was vital to the Future 
Experiences project, as it allowed the cohort 
to visualise the sort of environment where 
groundbreaking research and clinical trials are 
currently being conducted. It also provided them 
with access to some of the stakeholders who 
may benefit from their proposals and enabled 
them to consider the wider context surrounding 
their designs. A key takeaway from the visit 
was the importance of collaboration and the 
mutual benefit of co-location that the various 
practitioners pointed out. The Clinical Innovation 
Zone manifests the concept of knowledge 
exchange and co-creation. This informed the work 
of many students who chose to focus on joining 





























Throughout the research process, the students 
had opportunities to engage with industry 
experts from a range of specialisms, including 
medical oncologists, pathologists and researchers, 
as well as professors in molecular oncology and 
genetic medicine from the University of Glasgow. 
The experts were invited to join the students in 
their studio at the Innovation School, where they sat 
down with each group to discuss their STEEEPLE 
topic. As a cohort, the students identified the need 
to include the patient’s perspective in these informal 
workshop sessions. This viewpoint was provided in 
later workshops by Elspeth Banks, a cancer patient 
who represents patients on various committees, 
as well as contributing to several research and 
advisory groups.
For the students, having access to such 
experienced professionals and experts provided 
essential context and a level of personal insight 
to their research. They were able to ask targeted 
questions and learn about the everyday reality of 
working with cancer patients or living with the 
disease. They also gathered detailed information 
about the impact precision medicine is having on 
research, clinical trials, consultancy and logistics.
The experts shared with us their first-hand 
experiences and thoughts about precision medicine. 
They outlined key issues and provided honest insight 
that led to outstanding design opportunities. The 
experts also explained the broader ecosystem and the 
role each particular expert plays within an oncology 
and cancer care team. 









The collaboration with The University of 
Glasgow and the contacts provided by project 
partner, Professor Nicol Keith, in particular, 
were invaluable in ensuring that the students 
received input from a broad spectrum of 
stakeholders affected by precision medicine. This 
expert insight supplemented the desk research, 
informing the responses to the STEEEPLE cards 
and raising many additional questions about the 
likely impact of precision medicine on the entire 
ecosystem surrounding cancer care. 
Too often we put ourselves in the position of others 
and speculate about what industry, patients or the 
NHS might want or need. It’s much better to collate 
a sample group of people who are invested in the 
future of precision medicine, and who have opinions, 
skills and knowledge that could inform what’s actually 
required. Getting those people to think about the 
future in a way that frees them from the constraints of 
their everyday practice meant they were able to give 
shape and form to an alternative future.
Professor Nicol Keith
Interrogating the experts: workshops 
in the Haldane Building, GSA





For the experts, themselves, the workshops 
at the Innovation School represented a novel 
opportunity to discuss and re-examine their own 
practice in a creative context. The students were 
also able to probe aspects of their workflow and 
relationship with other stakeholders in ways 
that foregrounded efficiency and the needs of the 
various users.
The expert workshops are an example of the 
approach the Innovation School adopts to 
ensure projects focus on everyday experiences 
and improving people’s lives through targeted 
interventions. Following these sessions in the 
studio, several of the students followed up 
individually with experts working in an area 
that held particular interest or relevance for 
their chosen direction. These interactions lent a 
richness and depth of knowledge to their research 
presentations and are evidenced in the project 
outcomes. 
I was struck by the preparedness, motivation and 
enthusiasm of the students I worked with. They had 
prepared questions linked to their specific topic and it 
was clear that much thought had gone into this aspect 
of their work. The students are in a unique position 
to contribute blue-sky thinking to the project. They 
arrived with no baggage or preconceived ideas and it 
was refreshing to witness how they developed these 
original thoughts.





























Workshop 1: Mapping a Future Vision
The Innovation School’s extensive network 
of industry professionals, many of whom are 
alumni, enables it to organise practical teaching 
sessions that utilise the broad-ranging skills and 
experience of these expert practitioners. For the 
Future Experiences project, two workshops were 
arranged to help the students as they sought to 
translate their desk research into a tangible future 
vision. Lead tutor, Kirsty Ross, collaborated with 
the visiting designers to ensure the students 
received the right sort of information at the right 
time to benefit the flow of the project.
The first workshop run by Santini Basra 
of design strategy studio Andthen focused on 
techniques for analysing the STEEEPLE research 
and extracting key information related to the 
evolving cancer landscape. Andthen specialises in 
combining design research with futures thinking, 
and Basra demonstrated how the research could 
be used to map the potential future impact of 
























The research was translated into a range of 
speculative consequences, which generated 
further opportunities that become exponentially 
more visionary. In this way, the groups were 
able to focus on moments in the user journey that 
provided opportunities for innovation. 
This process challenged them to think beyond 
the obvious evolutionary steps for precision 
medicine and cancer care, and instead devise more 
radical outcomes that are beyond the realm of 
current thinking.
Often when you do desk research on topics like 
precision medicine you encounter the same sorts 
of consequences being discussed. These exercises 
pushed their thinking and helped them understand 
that everything exists within a bigger system where 
one change will lead to changes elsewhere.
Santini Basra, Studio Andthen
The final part of the workshop was a post mortem 
aimed at disposing of any opportunities that were 
either unfeasible, uninteresting, or not closely 
aligned with the goals of the project. At this point, 
the students were able to identify a specific area of 
interest for more targeted exploration.
Workshop 2: Creating a Future World
The second workshop led by designer and 
branding specialist Brian Proudfoot of Glasgow 
studio GOODD explored ways of manifesting 
the future world visions in visual and material 
form. The prototyping session focused on the 
production of physical communication artefacts 
that express ideas and tell a compelling story. 
The groups were encouraged to consider how 
the artefacts they created might relate to people, 
processes and practice. The outcomes could be 
anything from tools for collecting genomic data, 
to a vision for improvements in the way patients 
and consultants interact. Rather than creating 
refined prototypes, the intention was to help the 
groups solidify their thinking and generate a 
physical representation of their ideas.
The first stage of this workshop looked at 
creating value propositions that brought the 
research to life in the form of materials or images. 
These were applied to a grid that displayed the 
current and future landscape of each group’s 
dedicated STEEEPLE topic. The aim was to 
demonstrate that a future proposition could 
have a more approachable, understandable and 
integrated look and feel than the present. 
The students then developed experience maps 
based on the narrative journey of a particular 
user or user group. They were asked to quickly 
manifest a tangible exhibit based on the user 
journey using basic materials or items found 
around the studio. These interactive exhibits 
helped to tell a cohesive story that was easy to 
share with the rest of the cohort. Using found 
objects with existing associations helped to place 
the exhibits in a real-life context and made it 
simpler for anyone not immersed in the project to 



























Rapid prototyping with experiences















Some of the exhibits focused on representations 
of a familiar context, such as a bathroom cabinet 
that was adapted to contain futuristic artefacts 
used for harvesting physical samples or collecting 
data from users. Others chose a more abstract 
approach, such as using a see-through box with a 
DNA helix spiralling through it to represent the 
need for more transparency about who can access 
a patient’s genetic data. 
The syllabus at the Innovation School teaches 
different methods for communicating complex 
ideas in an intuitive way. We work with partners 
ranging from financial institutions to healthcare 
providers and social enterprises, so it is vital that 
our students can document processes, experiences 
and interactions using appropriate techniques. 
This level of communication goes well beyond 
what is typical in other fields and is different to 
the methods our partners may be used to. In the 
case of this project, the visiting medical experts 
and academics said they were impressed with the 
ability of the students to present complex ideas in 
a visual or physical format that made it possible to 
understand these concepts in a real-world context.
Thinking through making is a really good way of 
working. You can easily get caught up in paper 
and online research, but having to stop and make 
something is actually a great way to bring your 
thoughts together quickly. The workshop offered 
scope to determine the best way of communicating 
research in ways that encourage interaction and 
















































Students building experience 
prototypes in the workshop
RESEARCH 
PRESENTATION
The desk research culminated in a presentation 
of future visions developed by each of the eight 
groups in response to their designated topic. 
The format for the presentation saw the groups 
physically manifest the most significant research 
outcomes as part of a ‘future world’ scenario. The 
brief called for the creation of an experiential 
prototype that allowed the research to be 
accessed, understood and discussed by peers, staff 
and the public. Using a variety of prototyping 
methods and media to bring their visions to life, 
the teams demonstrated a range of potential 
implications of precision medicine on key areas 
within the cancer landscape.
Several of the groups developed personas 
based on their findings, which they used to depict 
real-life scenarios that could be affected by the 
adoption of genomic treatments. The Technology 
group, for example, presented a futuristic room 
set incorporating devices that unobtrusively 
gather health and lifestyle data from a patient 
– transforming them from a passive subject to 
an active participant in the research process. 
By volunteering to submit this data to the 
Community Health Index, for use by researchers 
and clinicians working on new applications for 
precision medicine, the patient may be prioritised 
when it comes to participating in a clinical 
trial. The presentation raised questions around 
the implications of technology’s future role as 
a discreet but powerful tool that is present in 
the home and is capable of altering the dynamic 
between patients, doctors and other organisations 









Other groups produced interactive exhibits 
that sought to immerse the viewer in different 
aspects of their future world. The Economics 
team created a series of artefacts to demonstrate 
how precision medicine might impact future 
fiscal approaches of businesses, consumers and 
policy makers across a range of scales. From the 
micro scale of a washbasin that gathers genomic 
data and rewards the user, to the macro scale of 
funding data centres capable of processing huge 
amounts of information, the exhibit employed 
simple models to facilitate interaction and a more 
intuitive appreciation for the issues arising from 
the research. 
The future visions helped to communicate vital 
information gathered throughout the research 
process to the other students, as well as the 
Innovation School faculty and visiting experts. In 
addition to providing insight into specific factors 
that affect the many stakeholders impacted by 
precision medicine, the group exhibition formed 
the basis for each student to identify a relevant 





































Research data was turned into 
































The exhibition of research allowed a wider 














Students sought to engage and 
include participants, the public 



















































Putting human experience at the 
centre of technological possibility
Nicol Keith
—Professor of Molecular Oncology
at The University of Glasgow
Nicol is Professor of Molecular Oncology and the Director 
of Research Impact at the Institute of Cancer Sciences. His 
research activities focus on translational cancer research 
including biomarker development, clinical trials and cancer cell 
immortality. He was the lead project partner on behalf of The 






















I had met with representatives 
from The Glasgow School of Art 
to talk about how they approach 
health and we quickly realised there 
was potential to work together on 
projects combining health and innovation. We looked at a few areas that 
might be worth exploring with the BDes students and settled on precision 
medicine because it felt really topical and matched the Innovation School’s 
intended learning outcomes. Also, Glasgow is a hub for this kind of work so 
there is a strong local interest in the future of precision medicine here.
What I wasn’t interested in was 
business as usual. Based on evidence 
that is already available I can 
see obvious benefits of precision 
medicine, but what’s interesting is to look at what this means if it becomes 
normal in the future. What impact does it have on patients, the healthcare 
system, the companies involved, the researchers? What does the whole 
ecosystem around it look like? Cancer precision medicine is still a nascent 
field so there was a great opportunity here to examine what’s missing by 
getting a different perspective.
It impressed me how quickly 
they reached a very high level of 
understanding about precision 
medicine, which is a very complex 
field. They exceeded my expectations with the way they picked up on the 
critical elements and what needed to be done. 
What I realised from the information the students presented was that there is 
more research to be done on precision medicine than I ever thought possible. 
My view of precision medicine was focused on finding another set of genes 
and seeing if we can target those with a drug. This process made me realise 
that we need to start acting on a wider range of projects associated with 
precision medicine so that in the future we are ready to ensure precision 
medicine is implemented in ways that genuinely enhance peoples’ lives.
The project catalysed a thought 
process that showed how cancer 
research or precision medicine is 
not limited to finding a new drug to 
target a certain set of mutations; it’s 
How did you get involved with 
this project and what appealed to 
you about working alongside the 
Innovation School?
What were your hopes and 
expectations for the project and what 
the students might come up with?
What did you make of the way the 
students approached this subject and 
the outcomes they presented? 
What was the real value of this project 
and how might the ideas you’ve 
witnessed make a difference to the 











far more than that because if we get that right there are many other things 
we need to have in place. That’s where the real value is for me. It opened up a 
way of finding real-world research questions that need to be addressed. 
I actually think a number of things they came up with are good prototypes 















































































The group research phase resulted in a range of 
future-world scenarios that provided a foundation 
for individual projects. The students were asked 
to design artefacts, services and experiences for 
the people inhabiting these future worlds. Each 
designer explored a range of concepts before 
choosing to focus on a specific aspect of precision 
medicine and its potential impact on their chosen 
future user.
Further workshops with Studio Andthen, as 
well as the Innovation School’s faculty, helped 
the students to clearly define the personality 
and needs of their intended users. The sorts of 
people identified as future users ranged from 
young patients learning to deal with the lifelong 
implications of a cancer diagnosis, to medical 
professionals requiring a more seamless way to 
incorporate new precision medicine procedures 
into their normal workflow.  
The design process involved a rigorous 
development and testing phase, with multiple 
ideas explored and refined before reaching a final 
outcome. Throughout this phase, the students 
narrowed their scope of thinking and ideas 
towards a targeted solution to a specific problem 
or issue. They visualised objects and experiences 
through sketching or model making to enable 
them to refine their proposals. This process was 
documented through a printed personal process 
journal that helped both the students and tutors  
to reflect on the work undertaken throughout  
the project.
The aim of the design phase was to deliver 
a compelling narrative, along with examples 
















strongly to the needs of the intended user and a 
specific scenario of use or experience. The final 
outcomes were expected to be highly resolved in 
terms of aesthetics, interactions and experiences. 
The completed proposals were presented for 
assessment in the form of a poster and short film 
or animation explaining their value and appeal. 
The students were also required to present a 
storyboard outlining the user journey and usage 




The eight-week project culminated in a work-
in-progress exhibition at Glasgow School of 
Art’s Reid Gallery, where the students presented 
their proposals to the public. Each of the groups 
exhibited the future visions they generated in 
the initial phase of the project. The individual 
outcomes were presented using a consistent 
format comprising a simple exhibition stand with 
space for an explanatory poster and additional 
models or other supporting materials. 
The Reid Gallery exhibition was visited by 
many of the medical academics and healthcare 
professionals who contributed to the project, 
as well as industry professionals, media and 
friends and family. The students used a variety of 
techniques to communicate their concepts, from 
films depicting products or digital interfaces in 
use, to three-dimensional models and speculative 
branding materials that demonstrated intelligent 
uses of form, colour, tactility and interaction. The 
exhibition enabled the students to gather valuable 
input that informed final refinements before 
the work was presented again at the end-of-year 
graduation show in June 2019. 
The WIP show was a fantastic test run in preparation for 
the final degree show. Exhibiting to the public at this stage 
helped me better understand how to clearly communicate 
my proposition and take into consideration how a first-time 
viewer is interpreting my work.










The work-in-progress exhibition was the first time 
we had seen the project in its entirety. Despite being 
involved in this project from its inception I was not 
prepared for the transformation taking place. The 
future experiences, whilst at times provocative, were 
justified and grounded in real-world relevance. 
Nicol Keith, Professor of Molecular Oncology 
DEGREE SHOW
At the end of the academic year, the graduating 
students presented their work to the public at 
the annual Glasgow School of Art Degree Show. 
Each student was given a dedicated area to exhibit 
their research and final outcome in the form of an 
explanatory poster, together with concept models 
and accompanying documentation. 
As with the mid-year work-in-progress 
exhibition, the Degree Show was attended by 
members of the public and many of the experts 
who were involved throughout the project. It gave 
the students an opportunity to present themselves 
professionally to various interested parties 
including the media, visiting designers, academics 
and industry professionals. The feedback from 
this event was overwhelmingly positive, with 
both patients and medical experts suggesting that 
the outcomes provided a realistic vision for the 
future of precision medicine and cancer care.
This project was a living ecosystem, constantly 
evolving in real time. There was a fearless originality 
to the work and a sense of ownership and social 
responsibility for the future of cancer care was 
inescapable. The range and diversity of vision, 
artefacts, outputs and in particular solutions, was 
beyond expectation and a disruption of my perception 






















































—Professor of Clinical Cancer Research 
at The University of Glasgow and Director of 
the Cancer Research UK Glasgow Trials Unit
Robert combines his academic work with his role as a busy 
clinician helping cancer patients to make informed treatment 
decisions. He contributed to the creation of the brief for 
the Future Experiences project and provided his unique 
perspective on the real-world implications of precision 























The pace of progress in molecular 
biology has been massively fast and 
has been driven by technological, 
knowledge and economic changes. 
However, there are a still lots of 
barriers to how we actually use that 
knowledge to improve outcomes for patients. A lot of hypotheses that seem 
obvious from a scientific point of view turn out to be much more complex 
when you actually sit down with a patient. I was hoping the students might 
approach this topic from a more user-centred point of view.
Precision medicine is clearly the way 
things are moving now in oncology, 
but the rate of scientific knowledge 
development has outpaced our ability 
to translate it into meaningful 
therapeutic changes for patients. 
I’m interested in asking what makes precision medicine therapy something 
that a patient would choose? People make assumptions that because a test 
predicts an outcome, therefore a patient would want to have the test. One 
of the prospects of this project was that it would identify and highlight the 
barriers to implementation, access and impact of precision medicine. 
I was very impressed by the 
students’ ability to understand 
what it is that scientists are trying 
to sell here because these are quite 
complex concepts. One of the things 
that really pleased me was the 
engagement of my fellow clinical and 
scientific colleagues. They were clearly enjoying and benefiting from their 
interactions with the students. 
The science community is currently 
being encouraged to consider and 
demonstrate how we address the 
impact of research. This is a great 
opportunity to explore impact in a 
novel way that goes beyond how scientists currently think about it. If the 
project causes the clinical science group to think more broadly about things 
then that in itself is an achievement. If it further enables us to highlight and 
Based on your experience working 
across molecular biology and clinical 
research, what are the key issues you 
hoped this Future Experiences project 
might be able to address?
How do you feel design might be able 
to help ensure precision medicine 
is applied in ways that are ethical, 
practical and genuinely beneficial to 
cancer patients?
You attended expert workshops 
organised by the students to 
gather information from medical 
professionals, academics, clinicians 
and patients. What did you make of 
these sessions?
What do you think is the value of this 
sort of project? What real-world 
consequences might it have on the 












identify areas where more work needs to be done, or to garner more interest 
in identifying and influencing areas of policy that need to be changed, then 










































































The Panoptic Choicagraph project imagines that 
in the year 2028 pharmaceutical companies will 
genetically engineer chickens to develop cancer-
fighting proteins for use in the development of 
personalised medicines. In this future scenario, 
recently diagnosed cancer patients enrol in an 
experimental trial for biosimilar drugs that can be 
engineered to suit a group of people with specific 
genetic mutations. Cells taken from the user 
would be inoculated via a process of embryonic 
transgenesis into eggs so that the hatched chicken 
would carry proteins to be used as part of their 
future treatment. The Panoptic Choicagraph 
device would be used during an initial consultation 
with the manager of a clinical trial and would allow 
the patient to choose their level of involvement and 











































Capsule is a new pharmaceutical-focused lifestyle 
brand that seeks to disrupt the current conceptual 
model associated with courses of cancer 
medication. Capsule aims to embed itself discreetly 
within the patient’s daily lifestyle and allow them 
to live their life emotionally separated from their 
illness. The target demographic for this project 
is young adults who are determined not to be 
defined by their illness. The refillable water bottle 
features a lid that conceals the pills in a special 
capsule chamber, allowing the user to load and 
swallow their medication discreetly. Capsule also 
helps its users to manage, track and record their 
recovery and share this information with medical 







































Perspective helps future cancer patents 
collaborate with their oncologist and clinical 
nurse to identify a suitable course of precision 
medicine. The service provides information about 
the experiences of previous patients with similar 
genetic profiles in visual, audible and tactile 
formats. Patients would be invited to speak with 
their oncologist and clinical nurse about aspects 
of their life and future ambitions that might affect 
the type of precision medicine they are prescribed. 
They would then be presented with 3D graphs 
depicting the emotional and physical journeys of 
previous patients, which they can feel to compare 
the various highs and lows. An augmented-reality 
lens provides layers of additional information as 
well as video testimonials from patients at different 



























This project explores the future relationship 
between artificial intelligence and clinical research 
– with a specific focus on how third-party lifestyle 
and environment data could be used to facilitate 
a more effective selection process for clinical 
trials. TrialSeek is a service which gathers and 
analyses an individual’s lifestyle and environment 
data in order to match them with a suitable trial. 
It comprises a wearable device that tracks the 
user’s activity and a portable sensor that gathers 
environmental data. This information is transferred 
to the TrialSeek network through wireless docks 
used to charge the devices. The data is used 
alongside other medical and lifestyle records 
to help the oncologist match the patient with a 













































MAIA is a voice-controlled digital health journal. 
The system is designed to alleviate the fear of 
cancer recurrence by providing guidance and 
support to survivors and their chosen loved ones 
in the form of visual and vocal feedback. Data 
gathered from a home blood test is analysed by 
medical professionals and sent to a main device 
that shares the results with the user. Care teams 
can communicate with the patient through the 
device to provide new instructions or schedule 
an appointment. A portable device tracks the 
user’s emotions and heart rate throughout the day, 
looking for worrying levels of stress. If it detects 
any concerning data, or the user manually enters 
abnormally negative feedback, Maia can alert the 










































This project envisions a new internal collective 
within the NHS to help staff keep up with the rapid 
pace of change affecting treatments, products and 
services. The organisation called Collective Care 
(CC) challenges stakeholders to review the future 
implications of precision medicine and how staff 
will use it to deliver better prospects for patients. 
The service bridges the gap between design and 
healthcare, with the ultimate aim of creating a 
more interdisciplinary system and developing 
innovative new management structures. A specially 
developed toolkit would be provided for use in 
multidisciplinary meetings held to determine 
a patient’s treatment, helping to sidestep 































































Adrianna Mozel  
—MOOT
MOOT is a brand that tackles the cancer taboo 
by creating tangible representations of tumours 
that are unique to each patient. By providing a 
patient with a physical model of their own mutation, 
MOOT aims to change how people relate to their 
disease. The objects can function as tools to 
enable conversations between family members 
and even strangers. The modular design can also 
be further customised depending on the treatment 
progress. The brand takes into consideration the 
understanding that some cancers remain terminal 




The efficacy of precision medicine is reliant on the 
availability of data relating to a patient’s genes, 
lifestyle and environment. Recent advances in 
epidemiology and geomedicine have contributed 
to more thorough health records and a better 
understanding of the complex relationships 
between the environment and human health. 
Biosence is a healthcare system that uses sensors 
incorporated into a wearable device to gather data 
about the environment we live in, including the food 
we eat, the water we drink and the air we breathe. 
The research from this programme, gathered by 
users all around the world, could contribute to 
increased awareness of key environmental factors 
affecting the evolution of precision medicine and 
cancer prevention.
Alexander Lister  
—Panoptic Choice 
The Panoptic Choicagraph project imagines that 
in the year 2028 pharmaceutical companies will 
genetically engineer chickens to develop cancer-
























By 2028, healthcare will be more seamlessly 
integrated into everyday life and routines. For this 
project, I was interested in the ways in which we 
consume medicines. As precision medicine evolves, 
it will allow treatments to be more targeted and 
have less severe side effects. With this in mind,  
can we transform treatment into a positive 
experience? Parlour provides cancer treatment in 
the form of ice cream. Using patients’ genetic data, 
collected via at-home testing, the parlour creates 
the perfect precision medicines within the perfect 




This project is based on a dystopian vision of a 
future in which precision medicine influences how 
people are viewed in society. In the envisioned 
scenario, increased cancer rates have prompted 
the introduction of mandatory health-monitoring 
devices. These implants use artificial intelligence 
to monitor the user’s diet, lifestyle and physical 
activity, which enables healthcare providers to 
prioritise treatments to those most in need. The 
role of the AI is to constantly analyse and feed 
back to the user on their personal device or smart 
devices in the home. The enforced use of the 
implant has caused a distinct divide in society 
between those diagnosed with a higher likelihood 
of developing cancer and those with more 
favourable data. Incorporated into the system is a 
tool called the Decision Maker that uses lifestyle 
choices, external factors and luck to place the user 























Capsule is a new pharmaceutical-focused 
lifestyle brand that seeks to disrupt the current 
conceptual model associated with courses of 
cancer medication. 
Charles Painter  
—Perspective 
Perspective helps future cancer patents 
collaborate with their oncologist and clinical 
nurse to identify a suitable course of precision 
medicine. The service provides information 
about the experiences of previous patients with 
























Bloc Care is a service connecting data from 
patients’ monitoring devices with the expertise of 
a clinician to improve the management of cancer 
treatment for all involved. Bloc Care is a mixture 
of digital application and physical tool kit. Bloc 
tools replace traditional offline apparatus such 
as the stethoscope. The application is accessible 
on a tablet. When Blocs are placed on the tablet 
they display data sets from the patient. Stacking 
Blocs overlays the data sets. This allows for early 
detection and treatment of symptoms, whilst 
contributing data to the precision medicine 
research pool. 
Clarisse Chapal  
—Educ-cell  
Educ Cell is an interactive platform for creating and 
storing physical models that manifest a patient’s 
healthcare data in a comprehensible format. The 
system creates a living 3D databank over time in 
order to help people learn collaboratively through 
the use of tangible objects. It can be difficult for 
doctors to announce a diagnosis to their patients, 
and patients sometimes struggle to understand 
their diagnosis because of the complexity of the 
information they are presented with. In order for 
designers to visualise complex scientific data 
they also need to educate themselves and know 
more about healthcare before designing for it. The 
Educ Cell platform is designed to help improve 
collaboration and communication between medical 
experts, their patients and designers, whether they 























NHS Homecare is a future service framework 
provided by the Scottish Healthcare System; 
specifically designed to cater for patients in 
unusual, remote locations. The service is based on 
the idea that in the future, healthcare will be more 
integrated into our home lives. NHS Homecare 
would be built into the patient’s treatment process 
following a significant event like chemotherapy 
or radiotherapy, when the patient is recovering 
alone at home. The patient would be provided 
with a collection of artefacts that would enable 
a dedicated treatment plan to be delivered and 
monitored remotely by the healthcare provider.
Emma Strain  
—Symbiotic Community  
Symbiotic Community responds to a societal shift 
that has seen more people providing companies 
and organisations with sensitive personal data. 
Advances in precision medicine are reliant on 
patients sharing data and Symbiotic Community 
aims to help bridge the gap between citizens 
and medical institutions, while ensuring patients 
are aware of what their data is being used for. A 
campaign across Glasgow linking together the 
creative industries, local councils and healthcare 
professionals creates a system to engage and 
inform individuals in unexpected and joyful ways. 
Artistic interventions designed to raise awareness 
of how precision medicine utilises personal genetic 
information would be placed in strategic locations 
across the city. Users approaching the artworks 
would find information to help them understand the 
need for data and encourage them to contribute to 























This project explores the future relationship 
between artificial intelligence and clinical research 
– with a specific focus on how third-party lifestyle 
and environment data could be used to facilitate a 
more effective selection process for clinical trials.
Eve Mccann  
—Alli 
Alli – Connected Emotional Care, is a connected 
suite of devices which aims to provide older cancer 
patients with a more tailored healthcare plan. 
The three devices manage data collected from 
the user’s digital interactions to detect changes 
in mood. Unusual activity is flagged in the nurse 
practitioner’s web portal. Through analysing and 
monitoring the patient’s digital behaviours, the 
nurse practitioner verifies whether these mood 
changes are medically related. The patient receives 
a notification on their self-reflective app and a 
domestic light-signalling tool glows brightly to 
alert the patient and other family members of 
the change in behaviour. The user then answers 
a series of questions through the app that are 























T•CARE is an artificial intelligence personal care 
assistant for future post-cancer patients. With 
more people anticipated to survive cancer in the 
future, the disease will likely be perceived as 
something more akin to a chronic illness than a 
terminal condition. Survivors will require dedicated 
care to adjust to life after cancer. AI technology 
offers an opportunity to provide tailored support 
during the remission stage, as a follow up to their 
course of precision medicine. T•CARE provides 
everyday support required to fulfil the patient’s 
medical, emotional or practical needs. The personal 
care assistant can be fully customised to resemble 
a loved one and can be accessed through devices 
such as a bracelet which allows a post-cancer 
patient to be accompanied by their hologram Care 
Manager wherever they go. 
Hanlin Zhang  
—2028 Pjc System 
The patient journey coordinator (PJC) system 
provides a new way to store a cancer patient’s 
documentation. Each PJC provides independent 
and specific directional services relating to an 
individual’s unique course of precision medicine 
treatment. In collaboration with professional 
doctors and a network of other staff offering 
tailored emotional support, the documentation 
detailing a patient‘s entire hospital journey will be 
improved. The data files relating to each patient 
will be being refined, eventually forming a medical 






















—Collaborative Research Facilitator 
Collaborative Research Facilitators are former 
patients who act as a bridge of communication 
between drug trial participants and researchers. 
The concept builds upon the existing role of the 
patient representative (PPI). In its current form the 
PPI service struggles with diversity and insufficient 
numbers of candidates as it has a number 
of barriers for most people who want to get 
involved. For example, it is unpaid and it requires 
candidates to bring transferrable skills with them. 
Taking advantage of the existing ties between 
hospital, university and art school, the facilitator 
would receive training provided by the different 
institution. This form of apprenticeship would 
allow them to become fluent in each stakeholder’s 
way of communicating and enable them to act as 
a translator between patient and researcher to 
enable enhanced collaboration. 
Marie Fremin-Besombes  
—Trial Engagement  
Clinical trials are essential to help develop 
treatments targeted at rare forms of cancer. 
Trial Engagement is a service that seeks to de-
stigmatise clinical trials and encourage patients 
to participate using a pair of engaging artefacts. 
An augmented-reality app allows the patient to 
visualise the extent of their cancer and compare 
their medical records with those of other 
patients to find the most appropriate clinical 
trial. A children’s book incorporating aspects of 
augmented reality helps parents to explain their 
cancer to their children. The service aims to make 
the patient a more active participant in the process 
























MAIA is a voice-controlled digital health journal. 
The system is designed to alleviate the fear of 
cancer recurrence by providing guidance and 
support to survivors and their chosen loved ones in 
the form of visual and vocal feedback.
Morrighan Humpleby  
—PreciseMe 
By 2028, precision medicine will have drastically 
improved cancer survival rates and many more 
people will be living and coping with cancer as a 
long-term illness. This scenario will lead to limited 
availability of space in hospitals and more patients 
will receive their treatment at home. PreciseMe is 
a modular care system for administering at-home 
treatment. Its modularity enables the system to 
adapt to a patient’s specific needs. The system of 
four main sections has over 80 combinations that 
can vary depending on medical factors such as 
what medical and diagnosis information the patient 
requires, the amount of toxic drugs within their 
treatment plan, but also the level of physical/verbal 























Perfect Us helps users to find a partner that is 
compatible on a genetic level, which can result in 
longer lasting and stronger relationships. Moreover, 
it offers an opportunity to find the perfect person 
for reproduction, making sure that the baby is just 
the way we want it to be: healthy, beautiful and 
cancer free. With help from precision medicine 
specialists, Perfect Us can minimise the likelihood 
of cancer occurring. The system uses a wearable 
device to analyse the air and identify particles of 
saliva normally found in human breath to find the 
perfect genomic match. When compatible saliva 
particles are detected the chip vibrates to guide 
the user towards their match. The Perfect Us app 
provides detailed descriptions about compatibility 
and possible reproductive information.
Sara Safrany  
—Boost
While precision medicine generates amazing 
results, the medicine is so precisely developed 
for certain cancers and specific mutations that 
it creates a hierarchy between patients the 
medicine is suitable for and those with a different 
genetic make up. BOOST is a service dedicated 
to filling the gaps between different patients by 
introducing them to clinical trials and boosting the 
development of different precision medicines. The 
system employs a wearable device that is capable 
of performing a small liquid biopsy. The data 
collected can be submitted to clinical trials around 
the world and the wearer is rewarded in return 
with monetary credits. The main aim is to make it 
easier for patients to gather and submit personal 
data that will facilitate new clinical trials and the 























The microbiome serves immunological, structural 
and metabolic functions. Disturbances in the normal, 
balanced state of healthful microbial communities 
known as dysbiosis, is significant in patients with 
colorectal cancer. Whether the gut microbiota 
maintains health or promotes colorectal cancer 
ultimately depends on the composition of the gut 
microbiome, and the balance within the microbial 
community of protective and detrimental bacteria 
populations. BiSeq is a device designed for patients 
with colorectal cancer to monitor the balance of their 
gut microbiota, and make changes to improve their 
metabolism and response to medication. The patient’s 
microbial data and reaction to drug therapies can be 
shared digitally with oncologists and other relevant 
medical professionals. This not only ensures that 
the patient is receiving the best treatment, but also 
drives further research in the development of better, 
more precise immunotherapies. 
Teresa Raina  
—Informed Consent for the Genomic Era
This project focuses on the issue of consent and 
how patients control the ways in which their 
private data is used. At a time of exponential 
growth in medical research, the role of consent has 
increased significance. The project looks at how we 
can make people more willing to contribute their 
personal genomic information to research, whilst 
increasing the population’s “genomic literacy”, 
enhancing engagement and ensuring transparency. 
The proposed system would see all citizens receive 
a package on their 21st birthday containing 
activities aimed at promoting conversations around 
the issue of genomic consent. The outcomes 
would be analysed by a counsellor and used to set 
consent preferences linked to the patient’s data. 
Patients would then have access to a dynamic 
consent platform where they could view how their 























This project envisions a new internal collective 
within the NHS to help staff keep up with the rapid 
pace of change affecting treatments, products and 
services. The organisation called Collective Care 
(CC) challenges stakeholders to review the future 
implications of precision medicine and how staff 
will use it to deliver better prospects for patients.
Zahra Merchant  
—Qube 
Qube was developed in collaboration with 
researchers at the Beatson Cancer Centre in 
Glasgow, and aims to make the clinical trial process 
more efficient, paperless and more transparent. 
The user-centred interface creates a shared 
network for supporting clinical trials related to 
cancer treatments. Qube utilises Blockchain 
technology, which allows data to be stored securely 
on a transparent and easily accessible platform. 
The service comprises the user interface and a 
biometric identity card that grants exclusive access 
to each stakeholder on the clinical trial network. 
The project’s main objective is to facilitate easier 
access to medical data and promote collaboration 

























































































The Future Experiences project is exemplary 
of the Innovation School’s unique approach to 
confronting key contemporary issues through 
innovative collaborative practice. Working 
alongside the University of Glasgow’s Institute 
of Cancer Sciences provided opportunities to 
gain first-hand insight into the emerging topic 
of precision medicine and its implications for 
the future of cancer care. The input of various 
academics, experts and patient representatives 
also contributed to outcomes that are grounded in 
reality, responding to problems and concerns that 
were raised during the intensive research phase.
During the project, the students adopted 
various methodologies for organising and 
directing their research, including the use of 
STEEEPLE cards that enabled them to cover a 
wide range of subtopics through group work and 
share their findings with the rest of the cohort. 
The inclusion of targeted workshops at key stages 
throughout the programme helped the students to 
identify unforeseen opportunities by imagining 
the future consequences of precision medicine, as 
well as teaching them methods for creating quick 
prototypes that allowed them to present their 
concepts in a clear and understandable way. The 
students described these workshops as “incredibly 
valuable” and “integral to our creative process”.
The intensive eight-week project culminated 
in a collection of sophisticated and considered 
outcomes that translated the group research into 
viable real-world proposals. The wide variety 
of future visions produced by the students 
demonstrates the scope of opportunity provided 












On each occasion I met with the students I was 
inspired by the way they were able to see things from 
a different angle to what I expected. They had very 
original ideas and approached them in a completely 
different way to my own students. I came away from 
the meetings with a list of thoughts that I personally 
felt are worth exploring in more detail. Some of the 
ideas could be put into practice in the years to come.
Ed Tobias, Professor of Genetic Medicine 
at the University of Glasgow
all of the projects, however, is a consistent focus on 
the needs of the user, which is evident in proposals 
ranging from new ways for cancer patients to take 
and monitor their course of treatment, to the use 
of physical tools and augmented reality to map a 
patient’s emotional journey.
For the students, this project offered a chance 
for them to utilise the skills and knowledge they 
have developed during their time at the Innovation 
School. One student described the experience as 
“a fascinating project that I thoroughly enjoyed”, 
adding that “because of the project’s complexity, I 
was able to develop my design thinking, research, 
and prototyping methods.” Another added that 
“I learned a lot about conducting research in a 
controlled way,” and claimed that “the Future 
Experiences project has exposed me to new 
topics and new design methods. This exposure 
has pushed me in my personal and practical 
development.”
The many contributors to the project, including 
medical academics, healthcare professionals, 
clinical scientists and patient representatives also 
claimed that the process had opened their eyes to 
the potential for designers to offer an alternative 
perspective on their practice. They were impressed 
with how the students approached such a 
complex topic and were able to quickly identify 
opportunities for meaningful change. Several of 
the experts expressed a willingness to continue 
their engagement with the students in order to 
further explore some of the issues and ideas raised 
during the project.
The collaboration with the University of Glasgow 
was a unique collaborative initiative that provided 
benefits for both parties. The Innovation School’s 
students had access to a wealth of knowledge 
and expertise in the emerging field of precision 
medicine, and the University of Glasgow was 
able to benefit from an alternative perspective on 
the subject it researches and teaches. This sort of 
collaborative practice is integral to the Innovation 
School’s approach to design innovation, and 
helps to prepare our students for the kinds of 
multidisciplinary projects they may encounter in 
their professional lives.
The varied outcomes of the Future Experiences 
project represent distinctly personal 
interpretations of a wide-ranging brief that 
challenged the students to examine new 
directions for a multifaceted topic. Precision 
medicine as a field of study will continue to evolve 
and expand over the coming years, and  the role of 
designers will become increasingly significant as 
healthcare providers, pharmaceutical companies 
and genetic scientists seek to identify suitable 
real-world applications. 
I enjoyed working with the Innovation School because 
it brought me into contact with experts in their field 
that I wouldn’t have come across in any other way. 
Working with the staff and students was tremendous 
because I got to see ways of working and thinking that 
are transferable across a whole range of projects. I also 
began to appreciate the unique skills and abilities that 
designers have. I now know that they are exceptional 
researchers and are able to quickly grasp complex 
concepts and turn them into something with real-world 
relevance or research potential. I could also see how 
in the future you might shape new ways of working by 
involving that sort of person in projects at a very early 
stage. They had no fear of the unknown and letting the 































The work of the Innovation School on this project 
outlines some of the key issues that will face 
society as this scenario unfolds, and provides 
insight into the role design might be able to play in 




Immediately following the completion and 
presentation of the Future Experiences project, 
our partners at the University of Glasgow 
compiled the various research and outcomes as an 
open science project with its own digital identifier 
(DOI) on the University’s data repository. This 
action makes it straightforward for anyone to 
access, navigate and retrieve resources relating 
to the project’s methodologies and findings, 
therefore enabling the work to be referenced in 
academic papers, reports and applications for 
grants or funding. 
By uploading the project to the data depository, 
it becomes part of the Open Scholarship 
programme. This will help to generate ongoing 
interest around the research, creating a legacy 
that is anchored to the institutes and people 
involved in its creation. Attributing a DOI to 
the project affirms its significance as a valuable 
example of academic study. It also ensures the 
provenance of the work is permanently recorded 
and any information used is traceable back to the 
originators. As part of an ongoing assessment of 
the project’s value, any interest associated with 
the DOI can be tracked and acknowledgements in 
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Bringing the GSA/UoG Cancer Precision Medicine 
collection together in this way as a data deposit with 
its own DOI is a major step forward and represents 
innovative thinking around how we address complex 
projects with multiple ‘data’ types/outputs and a 
range of contributors. The speed at which this was 
done is also an important factor in its value – as soon 
as the project was finished it was out in an organised 
meaningful collection format. It’s essentially real-time 
dissemination of results, knowledge and know-how.
By putting the collection in the repository we can also 
track interest. There has already been considerable 
interest in this work for a variety of reasons, some 
specific to an aspect of the project, while others are 
interested in the design innovation approach or indeed 
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Precision medicine is currently leading a healthcare 
revolution that places citizens at the centre of a discussion 
about their own care and wellbeing. This pioneering Future 
Experiences project by the Innovation School’s graduating 
BDes students examines how cancer care, in particular, can 
be tailored to meet the specific needs of individual patients. 
It explores the evolving landscape of cancer treatment and 
proposes alternative futures that are innovative, credible, 
practical and provocative.
